Further ancillary analyses were performed separately on participants in the sub-acute and chronic stage post- stroke to assess if the two treatments have different effects on these sub-groups. For both sub-groups ANCOVA tests were run to compare the change scores attained by the two treatment groups in all clinical and instrumented measures.